Work

Gestational Diabetes Mellitus and Maternal Epigenetic Age Acceleration During Pregnancy

Year: 2026
Type: dissertation
Study design: Observational Study
Abstract: IntroductionGestational diabetes mellitus (GDM) affects 10–20% of pregnancies globally and carries a seven- to ten-fold increased lifetime risk of type 2 diabetes. Pregnancy accelerates biological aging at the molecular level, yet whether GDM further amplifies this signal and whether metformin reduces it remains unknown. DNA methylation-based epigenetic clocks offer a quantitative tool to measure this acceleration beyond conventional glycemic biomarkers. ObjectivesThis study aimed to determine whether GDM is associated with increased epigenetic age acceleration (EAA) during pregnancy compared to non-GDM controls, and whether metformin-treated women show a reduction in EAA relative to untreated or lifestyle-managed GDM cases. MethodsA retrospective longitudinal analysis was conducted using DNA methylation data from two independent Qatari cohorts, the Qatar Birth Cohort (QBiC) and the Women's Wellness and Research Center cohort (WWRC). EAA was estimated using seven clocks: Horvath, Hannum, PhenoAge, GrimAge, GrimAge2, DNAmFitAge, and DunedinPACE, alongside PC-based refinements, computed as residuals adjusting for chronological age, BMI, and batch. Trajectories were examined across first to third trimester (T1–T3) and second to third trimester (T2–T3) gestational windows across four groups: non-GDM controls, untreated GDM patients, lifestyle-managed GDM patients, and metformin-treated GDM patients.ResultsGDM cases showed consistently higher EAA than controls across both cohorts. In the treatment-stratified analyses, the untreated GDM group showed the highest PhenoAge EAA increase, while the metformin group showed a decline, ending with a lower EAA at T3. ConclusionGDM is associated with accelerated maternal epigenetic aging during pregnancy. GrimAge, GrimAge2, and DunedinPACE were the most robust and reproducible signals across the two cohorts. Metformin may reduce this epigenetic age acceleration.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7233749534
Cites:
Cited by:
Related to: 10